T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. 2010

Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
Institute of Immunology, Key Laboratory for Experimental Teratology of Ministry of Education, Shandong University School of Medicine, #44 Wenhua Xi Road, Jinan, Shandong, PR China.

OBJECTIVE T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) has been shown to influence autoimmune diseases; however, its function in viral infection has not been well-defined. We therefore investigated the expression and regulatory function of Tim-3 in natural killer (NK) cells in chronic Hepatitis B (CHB) infection. METHODS Seventy-six CHB patients, 38 healthy controls, and 18 patients with fatty liver disease (FLD) were tested for Tim-3 expression on peripheral blood mononuclear cells (PBMCs) and in the liver tissue by flow cytometry and immunohistochemical stainning. The effects of HBV infection on Tim-3 expression in NK cells and the roles of Tim-3 in regulation of NK-cell function were also studied. RESULTS There was a significant increase of Tim-3 expression in PBMCs, circulating NK cells and liver infiltrating lymphocytes (LILs) from CHB patients compared to that of healthy controls and FLD patients. Increased Tim-3 expression was also detected in NK92 cells that had been transfected with a HBV expression vector and NK cells isolated from the liver of HBV transgenic mice. Importantly, blockage of Tim-3 signaling with anti-Tim-3 antibodies or Tim-3-Fc fusion proteins resulted in an increased cytotoxicity for NK92 cells compared to HepG2 and HepG2.2.15 cells, as well as an elevated interferon-gamma (IFN-gamma) production. Similarly, enhanced cytotoxicity was also observed in PBMCs or NK cells from CHB patients treated with the Tim-3 blockade ex vivo. CONCLUSIONS HBV infection can up-regulate Tim-3 expression in NK cells, which may in turn suppress NK-cell functions in CHB patients.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse

Related Publications

Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
May 2012, Atherosclerosis,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
July 2017, Hematology (Amsterdam, Netherlands),
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
October 2021, Journal of medicinal chemistry,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
March 2012, Journal of dermatological science,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
May 2015, Clinical immunology (Orlando, Fla.),
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
August 2023, International immunopharmacology,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
January 2014, PloS one,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
May 2024, Journal of immunotherapy and precision oncology,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
July 2012, DNA and cell biology,
Ying Ju, and Nan Hou, and Jing Meng, and Xiaoyan Wang, and Xiaoning Zhang, and Di Zhao, and Ying Liu, and Faliang Zhu, and Lining Zhang, and Wensheng Sun, and Xiaohong Liang, and Lifen Gao, and Chunhong Ma
October 2011, Helicobacter,
Copied contents to your clipboard!